BioSpace News Archive

Cannabics Pharmaceuticals Inc. announced that it has appointed two new independent directors to its board of directors, Dr. Estery Giloz-Ran and Eran Ballan, Esq.

Healthcare workers renew efforts to increase HIV testing as part of a national strategy to make best use of highly effective tools now available – specifically, HIV treatment and pre-exposure prophylaxis (PrEP)

With a five-year survival rate still at just 9 percent, the Pancreatic Cancer Action Network (PanCAN) mobilized more than 600 pancreatic cancer survivors, caregivers and advocates from across the country to urge their congressional representatives to fund more research into the world’s deadliest cancer.

Ventech Solutions, Inc., has appointed Brian Burwell as Vice President of Healthcare Policy and Research. I

“Two words: Excellent choice. Judy Persichilli started her career as an RN at the bedside caring for patients. She remained true to that commitment as she became CEO at St. Francis Medical Center in Trenton, Catholic Health East and more recently, interim CEO at University Hospital

Amgen (NASDAQ:AMGN) and MBC BioLabs (formerly QB3@953) today announced that Regencor and Nitrome Biosciences have each been awarded an Amgen Golden Ticket to MBC BioLabs.

Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, announced that 12-month results from the Company’s Early Feasibility Study of the Orion® Visual Cortical Prosthesis System

According to Technavio Research Report “Alcoholic Hepatitis Treatment Market by type, and geographic regions is witnessed to grow by USD 570 million, at a CAGR of 6% from 2019 to 2023”.

Phase 1/2 clinical trial to evaluate Intensity’s INT230-6 in combination with KEYTRUDA® (pembrolizumab) for multiple solid tumor types

BPX-04 met both primary and secondary endpoints with statistical significance